Human T-cell lymphotropic virus type-1 infection and risk of cancer: 15.4 year longitudinal study among atomic bomb survivors in Nagasaki, Japan

Cancer Science

Volumn 97, Issue 6, 2006, Pages 535-539

  Arisawa, Kokichi ^a   Soda, Midori ^b   Akahoshi, Masazumi ^b   Fujiwara, Saeko ^b   Uemura, Hirokazu ^a   Hiyoshi, Mineyoshi ^a   Takeda, Hideo ^a   Kashino, Wataru ^a   Suyama, Akihiko ^b  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; ATOMIC BOMB SURVIVOR; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; COLON CANCER; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEALTH SURVEY; HEPATITIS C VIRUS; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; JAPAN; LIVER CANCER; LONGITUDINAL STUDY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; RECTUM CANCER; SEROPREVALENCE; STOMACH CANCER; SUPERINFECTION; T CELL LEUKEMIA; THYROID CANCER; VIRUS CARRIER;

FEMALE; HTLV-I INFECTIONS; HUMANS; INCIDENCE; JAPAN; LONGITUDINAL STUDIES; MALE; NEOPLASMS; NUCLEAR WARFARE; RADIOACTIVE FALLOUT; RISK FACTORS; SURVIVORS;

EID: 33744538321     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2006.00212.x     Document Type: Article

References (38)

1. IARC. Human T-cell lymphotropic viruses. In. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 67: Human Immunodeficiency Viruses and Human T-cell lymphotropic viruses. Lyon: IARC, 1996; 261-390.
2. Mueller NE, Blattner WA. Retroviruses-human T-cell lymphotropic virus. In: Evans AS, Kaslow RA, eds. Viral Infections of Humans. Epidemiology and Control, 4th edn. New York and London: Plenum, 1997; 785-813.
3. Hino S. Primary prevention of adult T cell leukemia (ATL) in Nagasaki, Japan by refraining from breast-feeding. Gann Monograph Cancer Res 2003; 50: 241-51.
4. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: Collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women with breast cancer and 96 9 73 women without the disease. Lancet 2002; 360: 187-95.
5. Tajima K, Kuroishi T. Estimation of rate of incidence of ATL among ATLV (HTLV-I) carriers in Kyushu, Japan. Jpn J Clin Oncol 1985; 15: 423-30.
6. Cleghorn FR, Manns A, Falk R et al. Effect of human T-lymphotropic virus type I infection on non-Hodgkin's lymphoma incidence. J Natl Cancer Inst 1995; 87: 1009-14.
7. Arisawa K, Soda M, Endo S et al. Evaluation of adult T-cell leukemia/ lymphoma incidence and its impact on non-Hodgkin lymphoma incidence in southwestern Japan. Int J Cancer 2000; 85: 319-24.
8. Kaplan JE, Osame M, Kubota H et al. The risk of the development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. J Acquir Immune Defic Syndr 1990; 3: 1096-101.
9. Asou N, Kumagai T, Uekihara S et al. HTLV-I seroprevalence in patients with malignancy. Cancer 1986; 58: 903-7.
10. Kozuru M, Uike N, Muta K, Goto T, Suehiro Y, Nagano M. High occurrence of primary malignant neoplasms in patients with adult T-cell leukemia/ lymphoma, their siblings, and their mothers. Cancer 1996; 78: 1119-24.
11. Matsuzaki H, Asou N, Kawaguchi Y et al. Human T-cell leukemia virus type 1 associated with small cell lung cancer. Cancer 1990; 66: 1763-8.
12. Miyazaki K, Yamaguchi K, Tohya T, Ohba T, Takatsuki K, Okamura H. Human T-cell leukemia virus type I infection as an oncogenic and prognostic risk factor in cervical and vaginal carcinoma. Obstet Gynecol 1991; 77: 107-10.
13. Strickler HD, Rattray C, Escoffery C et al. Human T-cell lymphotropic virus type I and severe neoplasia of the cervix in Jamaica. Int J Cancer 1995; 61: 23-6.
14. Nerenberg M, Hinrichs SH, Reynolds RK, Khoury G, Jay G. The tat gene of human T-lymphotropic virus type 1 induces mesechymal tumors in transgenic mice. Science 1987; 237: 1324-9.
15. Iwakura Y, Tosu M, Yoshida E et al. Augmentation of c-fos and c-jun expression in transgenic mice carrying the human T-cell leukemia virus type-I tax gene. Virus Genes 1994; 9: 161-70.
16. Green JE, Baird AM, Hinrichs SH, Klintworth GK, Jay G. Adrenal medullary tumors and iris proliferation in a transgenic mouse model of neurofibromatosis. Am J Pathol 1992; 140: 1401-10.
17. Yamada S, Ikeda H, Yamazaki H et al. Cytokine-producing mammary carcinomas in transgenic rats carrying the pX gene of human T-lymphotropic virus type I. Cancer Res 1995; 55: 2524-7.
18. Arisawa K, Sobue T, Yoshimi I et al. Human T-lymphotropic virus type-I infection, survival and cancer risk in southwestern Japan: A prospective cohort study. Cancer Causes Control 2003; 14: 889-96.
19. Atomic Bomb Casualty Commission. Research plan for joint ABCC-NIH Adult Health Study in Hiroshima and Nagasaki, Japan. Hiroshima and Nagasaki: ABCC Technical Report, 1962; 11-62.
20. Arisawa K, Soda M, Akahoshi M et al. Human T-lymphotropic virus type-I infection, antibody titers and cause-specific mortality among atomic-bomb survivors. Jpn J Cancer Res 1998; 89: 797-805.
21. Matsuo T, Nakashima E, Carter RL et al. Anti-Human T-lymphotropic virus type-I antibodies in atomic-bomb survivors. J Radiat Res, 1995; 36: 8-16.
22. Fujiwara S, Kusumi S, Cologne J, Akahoshi M, Kodama K, Yoshizawa H. Prevalence of anti-hepatitis C virus antibody and chronic liver disease among atomic bomb survivors. Radiat Res 2000; 154: 12-19.
23. Fujiwara S, Sharp GB, Cologne JB et al. Prevalence of hepatitis B virus infection among atomic bomb survivors. Radiat Res 2003; 159: 780-6.
24. Soda M, Ikeda T. Japan, Nagasaki Prefecture. In: Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J, eds. Cancer Incidence in Five Continents, vol. VII. Lyon: IARC Scientific Publications, 1997; 390-3.
25. Collett D. Modelling Survival Data in Medical Research. London: Chapman & Hall, 1994; 253-65.
26. Manel N, Kim FJ, Kinet S, Taylor N, Sitbon M, Battini JL. The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV. Cell 2003; 115: 449-59.
27. Sharp GB, Lagarde F, Mizuno T et al. Relationship of hepatocellular carcinoma to soya food consumption: A cohort-based, case-control study in Japan. Int J Cancer 2005; 115: 290-5.
28. Okamoto M, Nagata I, Murakami J et al. Prospective reevaluation of risk factors in mother-to-child transmission of hepatitis C virus: High virus load, vaginal delivery, and negative anti-NS4 antibody. J Infect Dis 2000; 182: 1511-14.
29. Jeffery KJ, Usuku K, Hall SE et al. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci USA 1999; 96: 3848-53.
30. Tanaka G, Okayama A, Watanabe T et al. The clonal expansion of human T lymphotropic virus type 1-infected T cells: A comparison between seroconverters and long-term carriers. J Infect Dis 2005; 191: 1140-7.
31. Kishihara Y, Furusyo N, Kashiwagi K, Mitsutake A, Kashiwagi S, Hayashi J. Human T lymphotropic virus type 1 infection influences hepatitis C virus clearance. J Infect Dis 2001; 184: 1114-9.
32. Boschi-Pinto C, Stuver S, Okayama A et al. A follow-up study of morbidity and mortality associated with hepatitis C virus infection and its interaction with human T lymphotropic virus type I in Miyazaki, Japan. J Infect Dis 2000; 181: 35-41.
33. Isomoto H, Mizuta Y, Fukushima K et al. Low prevalence of Helicobacter pylori in individuals with HTLV-I infection. Eur J Gastroenterol Hepatol 1999; 11: 497-502.
34. Cacciarelli AG, Marano BJ Jr, Gualtieri NM et al. Lower Helicobacter pylori infection and peptic ulcer disease prevalence in patients with AIDS and suppressed CD4 counts. Am J Gastroenterol 1996; 91: 1783-4.
35. Welles SL, Tachibana N, Okayama A et al. Decreased reactivity to PPD among HTLV-I carriers in relation to virus and hematologic status. Int J Cancer 1994; 56: 337-40.
36. Okayasu I, Fujiwara M, Hara Y, Tanaka Y, Rose NR. Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. A study of surgical cases among Japanese, and white and African Americans. Cancer 1995; 76: 2312-18.
37. Akamine H, Takasu N, Komiya I et al. Association of HTLV-I with autoimmune thyroiditis in patients with adult T-cell leukaemia (ATL) and in HTLV-I carriers. Clin Endocrinol 1996; 45: 461-6.
38. Hsieh CC, Tzonou A, Zavitsanos X, Kaklamani E, Lan SJ, Trichopoulos D. Age at first establishment of chronic hepatitis B virus infection and hepatocellular carcinoma risk. A birth order study. Am J Epidemiol 1992; 136: 1115-19.